Total Payments
$9,328
2024 Payments
$1,883
Companies
32
Transactions
459
Medicare Patients
5,824
Medicare Billing
$384,934
Payment Breakdown by Category
Food & Beverage$9,271 (99.4%)
Education$56.82 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,271 | 455 | 99.4% |
| Education | $56.82 | 4 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,889 | 85 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $982.97 | 52 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $971.45 | 50 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $874.34 | 46 | $0 (2024) |
| Amgen Inc. | $840.36 | 37 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $727.38 | 48 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $492.61 | 21 | $0 (2024) |
| Merck Sharp & Dohme LLC | $298.04 | 16 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $278.65 | 18 | $0 (2024) |
| Novo Nordisk Inc | $204.38 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,883 | 89 | PFIZER INC. ($354.56) |
| 2023 | $1,777 | 80 | PFIZER INC. ($327.64) |
| 2022 | $1,514 | 78 | PFIZER INC. ($399.47) |
| 2021 | $1,279 | 69 | PFIZER INC. ($213.98) |
| 2020 | $933.90 | 44 | PFIZER INC. ($209.29) |
| 2019 | $1,044 | 52 | PFIZER INC. ($274.01) |
| 2018 | $594.70 | 31 | AstraZeneca Pharmaceuticals LP ($116.08) |
| 2017 | $302.54 | 16 | Amgen Inc. ($77.10) |
All Payment Transactions
459 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: Cardiology | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.42 | General |
| Category: Cardiovascular | ||||||
| 11/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: DIABETES | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $2.35 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $30.87 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/19/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: Not Applicable | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $2.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.82 | General |
| Category: Cardiovascular | ||||||
| 11/05/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.11 | General |
| 10/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: Cardiology | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/14/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $34.62 | General |
| Category: Coronary | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/08/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $16.58 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/02/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/01/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $28.23 | General |
| Category: Cardiovascular | ||||||
| 09/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $29.69 | General |
| Category: Cardiology | ||||||
| 09/19/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $26.89 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $2.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: DIABETES | ||||||
| 09/13/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Cardiology | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,521 | 2,224 | $496,317 | $115,366 |
| 2022 | 14 | 1,472 | 2,146 | $439,213 | $102,383 |
| 2021 | 13 | 1,471 | 2,297 | $376,953 | $93,346 |
| 2020 | 12 | 1,360 | 2,088 | $318,690 | $73,839 |
Total Patients
5,824
Total Services
8,755
Medicare Billing
$384,934
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 183 | 328 | $121,032 | $32,417 | 26.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 158 | 160 | $120,840 | $24,477 | 20.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 27 | 27 | $43,794 | $9,650 | 22.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 127 | 129 | $27,477 | $7,081 | 25.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 53 | 56 | $26,712 | $5,847 | 21.9% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 28 | 53 | $9,225 | $5,048 | 54.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 469 | 661 | $17,186 | $4,315 | 25.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 193 | 371 | $21,147 | $4,231 | 20.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 36 | 62 | $15,810 | $3,939 | 24.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 22 | 82 | $20,500 | $3,420 | 16.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 50 | 50 | $13,200 | $3,054 | 23.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $12,075 | $3,028 | 25.1% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 32 | 46 | $14,766 | $2,220 | 15.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 19 | 19 | $9,975 | $2,031 | 20.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 16 | 18 | $6,642 | $1,409 | 21.2% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 30 | 30 | $7,620 | $1,340 | 17.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 18 | $4,428 | $930.58 | 21.0% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 16 | 67 | $2,580 | $615.78 | 23.9% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Office | 2023 | 11 | 12 | $948.00 | $232.20 | 24.5% |
| 93270 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | Office | 2023 | 11 | 12 | $360.00 | $82.13 | 22.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 175 | 307 | $113,283 | $28,373 | 25.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 159 | 161 | $121,600 | $25,044 | 20.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 25 | 25 | $40,550 | $9,664 | 23.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 147 | 151 | $32,163 | $8,642 | 26.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 549 | 798 | $20,748 | $5,358 | 25.8% |
About Dr. Shih-Te Wen, MD
Dr. Shih-Te Wen, MD is a Internal Medicine healthcare provider based in Newburyport, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1801887997.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shih-Te Wen, MD has received a total of $9,328 in payments from pharmaceutical and medical device companies, with $1,883 received in 2024. These payments were reported across 459 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($9,271).
As a Medicare-enrolled provider, Wen has provided services to 5,824 Medicare beneficiaries, totaling 8,755 services with total Medicare billing of $384,934. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Newburyport, MA
- Active Since 10/29/2005
- Last Updated 01/19/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1801887997
Products in Payments
- ELIQUIS (Drug) $2,048
- XARELTO (Drug) $856.35
- Repatha (Biological) $618.86
- FARXIGA (Drug) $522.35
- ENTRESTO (Drug) $422.16
- VYNDAQEL (Drug) $418.84
- LEQVIO (Drug) $305.22
- BRILINTA (Drug) $300.31
- VERQUVO (Drug) $298.04
- JARDIANCE (Drug) $258.93
- CAMZYOS (Drug) $252.22
- PRADAXA (Drug) $233.68
- Corlanor (Drug) $214.16
- Ozempic (Drug) $180.24
- NEXLETOL (Drug) $177.89
- Vascepa (Drug) $167.72
- Arcalyst (Drug) $151.78
- CHANTIX (Drug) $141.29
- FFRct (Device) $134.60
- UPTRAVI (Drug) $130.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Newburyport
Dr. Michael Mccartney, M.d, M.D
Internal Medicine — Payments: $53,704
Internal Medicine $53,704
Houtan Golzari, M.d, M.D
Internal Medicine — Payments: $18,905
Internal Medicine $18,905
Dr. Julie Geary, Md, MD
Internal Medicine — Payments: $6,743
Internal Medicine $6,743
Dr. Anthony Eaton, M.d, M.D
Internal Medicine — Payments: $4,029
Internal Medicine $4,029
Lydia Jeffcoat, Md, MD
Internal Medicine — Payments: $2,569
Internal Medicine $2,569
Saira Naseer, Md, MD
Internal Medicine — Payments: $1,924
Internal Medicine $1,924